TRAVERE THERAPEUTICS, INC. Employee Benefits and Share-based Compensation
TRAVERE THERAPEUTICS, INC. (TVTX) reported Employee Benefits and Share-based Compensation of $478.74 thousand for the 3-month period ending 2013-09-30, per its 10-Q/A filed 2015-07-09.
Discontinued › Notes › Compensation Related Costs
us-gaap:EmployeeBenefitsAndShareBasedCompensation · last filed 2015-07-09
- TRAVERE THERAPEUTICS, INC. employee benefits and share-based compensation for the quarter ending 2013-09-30 was $478.74K, a 90.55% decline year-over-year.
- TRAVERE THERAPEUTICS, INC. employee benefits and share-based compensation for the quarter ending 2013-06-30 was $492.13K, a 67.90% decline year-over-year.
- TRAVERE THERAPEUTICS, INC. employee benefits and share-based compensation for the quarter ending 2013-03-31 was $1.05M, a 40.94% decline year-over-year.
- TRAVERE THERAPEUTICS, INC. employee benefits and share-based compensation for the quarter ending 2012-12-31 was $9.76M.
- TRAVERE THERAPEUTICS, INC. employee benefits and share-based compensation for fiscal 2012 was $18.13M.
| Period end | Employee Benefits and Share-based Compensation 3 month | Employee Benefits and Share-based Compensation 6 month | Employee Benefits and Share-based Compensation 9 month | Employee Benefits and Share-based Compensation 10 month | Employee Benefits and Share-based Compensation 12 month | Employee Benefits and Share-based Compensation 22 month | Employee Benefits and Share-based Compensation 25 month | Employee Benefits and Share-based Compensation 28 month | Employee Benefits and Share-based Compensation 31 month |
|---|---|---|---|---|---|---|---|---|---|
| 2013-09-30 | $478.74K 10-Q/A · filed 2015-07-09 | $970.87K derived: sum of 2 quarters · filed 2015-07-09 | $1.77M 10-Q/A · filed 2015-07-09 | $11.78M derived: sum of 4 quarters · filed 2015-07-09 | $22.13M 10-Q/A · filed 2015-07-09 | ||||
| 2013-06-30 | $492.13K 10-Q · filed 2013-09-16 | $1.54M 10-Q · filed 2013-09-16 | $11.30M derived: sum of 3 quarters · filed 2013-09-16 | $16.37M derived: sum of 4 quarters · filed 2015-07-09 | $21.90M 10-Q · filed 2013-09-16 | ||||
| 2013-03-31 | $1.05M 10-Q/A · filed 2013-09-16 | $10.81M derived: sum of 2 quarters · filed 2013-09-16 | $15.88M derived: sum of 3 quarters · filed 2015-07-09 | $17.41M derived: sum of 4 quarters · filed 2015-07-09 | $21.41M 10-Q/A · filed 2013-09-16 | ||||
| 2012-12-31 | $9.76M derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2013-09-16 | $14.83M derived: sum of 2 quarters · filed 2015-07-09 | $16.36M derived: sum of 3 quarters · filed 2015-07-09 | $18.13M 10-K/A · filed 2013-09-16 | $20.36M 10-K/A · filed 2013-09-16 | ||||
| 2012-09-30 | $5.07M 10-Q/A · filed 2015-07-09 | $6.60M derived: sum of 2 quarters · filed 2015-07-09 | $8.37M 10-Q/A · filed 2015-07-09 | ||||||
| 2012-06-30 | $1.53M 10-Q · filed 2013-09-16 | $3.30M 10-Q · filed 2013-09-16 | |||||||
| 2012-03-31 | $1.77M 10-Q/A · filed 2013-09-16 | ||||||||
| 2011-12-31 | $2.23M 10-K/A · filed 2013-09-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |